Supplier specifications and documentation vary by supplier and batch
There is no consistent, reproducible body of evidence [supporting increased suicidal ideation]
In this study, we utilized the international TriNetX platform to assess whether GLP-1RAs could mitigate long-term adverse outcomes in diabetic KTRs
However, its important to note that the safety of peptides can vary depending on the specific peptide, dosage, individual health conditions, and how they are used
Another potential option would be to replace the GLP- 1 RA as the backbone with another agent
Pancreatitis, though uncommon with an incidence of less than one percent, represents a potentially serious complication that requires immediate medical attention